NSE ScannerHospitals & Diagnostics · Hospital/Nursing Management · NSE: MANIPALHOS · data 2026-10-30
Manipal Health Enterprises Limited
In plain words
Price: 17.9% below its 52-week high of ₹815.
Delivery: 56.9% of traded shares were kept for delivery over the last 10 sessions, against 50.7% over the last 60.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | — |
| Net profit (last 12 months) | — |
| Sales growth, 3 years (yearly) | 28.8% |
| Profit growth, 3 years (yearly) | 28.3% |
At a glance
Promoters 72.1%, pledged 8.5%, institutions 10.7%.
ROE 12.5%, ROCE 11.5%: how much profit it earns on the money it uses.
Debt/equity 1.53, Profit growth 28.3% and sales growth 28.8% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Profit grew 28.3% a year over 3 years.
- High borrowing: debt/equity 1.53.
- Promoters have pledged 8.5% of their shares.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
23/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 4/30: Delivery 56.2% over the last 20 sessions vs 55.0% in the 40 before (1.02x); shares delivered per day 0.27x usual; 1 delivery-spike day (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 6/15: 0 insider buy days (promoter group among them) and 1 SAST acquisition day in 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 7/15: 4 schemes hold it, about ₹491 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 1/15: Verdict "None", sustained score 30/100.
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Deal ● Insider
- 21 Oct 26Deal Block deal: PI OPPORTUNITIES AIF V LLP bought ₹119.57 cr (net ₹0 cr) -0.7% next session
- 13 Aug 26Insider SAST disclosure: Vistra ITCL (India) Limited +2 acquired 77,21,16,146 shares +2.1% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Shareholding trend
| Holder | Sept 2026 |
|---|---|
| Promoters | 72.08% |
| Foreign institutions (FII) | 3.50% |
| Domestic institutions (DII) | 7.18% |
| Mutual funds | 4.63% |
| Retail investors | 1.04% |
| Number of shareholders | 1,72,129 |
Common questions
How much do promoters hold in Manipal Health Enterprises Limited?
Promoters held 72.08% of Manipal Health Enterprises Limited at the end of Sept 2026, with 8.48% of promoter shares pledged.
Is Manipal Health Enterprises Limited debt-free?
Its latest reported debt-to-equity ratio is 1.53, meaning borrowings are larger than shareholders' equity.
What is the 52-week high and low of Manipal Health Enterprises Limited?
The 52-week high is ₹815 and the 52-week low is ₹597.
Mutual funds holding Manipal Health Enterprises Limited
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 4 schemes holding about ₹491 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| Mirae Asset Midcap Fund | Mirae Asset Mutual Fund | 0.95% | ₹186 cr |
| Mirae Asset Focused Fund | Mirae Asset Mutual Fund | 2.74% | ₹174 cr |
| ADITYA BIRLA SUN LIFE MIDCAP FUND | Aditya Birla Sun Life Mutual Fund | 1.83% | ₹120 cr |
| ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND | Aditya Birla Sun Life Mutual Fund | 1.07% | ₹12 cr |
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Manipal Health Enterprises Limited | ₹669.15 | ₹84,033 cr | — | — | 12.5% | 11.5% | 1.53 | +2.6% |
| Apollo Hospitals Enterprise Limited | ₹8,448 | ₹1,20,779 cr | 58.2 | — | 21.9% | 18.5% | 0.9 | +8.8% |
| Max Healthcare Institute Ltd | ₹860 | ₹83,705 cr | 57.7 | — | 14.3% | 12.9% | 0.32 | -27.5% |
| Aster DM Quality Care Limited | ₹681.15 | ₹59,570 cr | 110.5 | — | 9.7% | 10.3% | 0.49 | -2.7% |
| Fortis Healthcare Ltd. | ₹768.15 | ₹58,117 cr | 55.3 | — | 11.1% | 12.3% | 0.35 | -27.2% |
| Narayana Hrudayalaya Ltd. | ₹1,720.2 | ₹35,144 cr | 42.8 | — | 19.8% | 14.5% | 1.29 | -4.4% |
Compare MANIPALHOS with APOLLOHOSP in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open MANIPALHOS in NSE Scanner →